India to British Virgin Islands Pharmaceutical Export (2026) — $485.3K, 16 Suppliers | TransData Nexus

India to British Virgin Islands Pharmaceutical Export (2026) — $485.3K, 16 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to British Virgin Islands

#	Formulation	Value	Share
1	Tenofovir Disoproxil Fumarate300 MG +efavirenz600mg+emtricitabine200mgtab30s (2…	$36.9K	7.6%
2	Contain Medicines Harmless Pharmaceutical Products- Darzalex 400mg Injection (2…	$16.3K	3.4%
3	Darzalex 400mg Injection (20 Ml) Daratumumab	$14.5K	3.0%
4	Contain Medicines Harmless Pharmaceutical Products - Darzalex 400mg Injection (…	$12.7K	2.6%
5	Enzalutamide 160mg Tablet -brand Name-glenza 160mg Tablet	$7.5K	1.5%
6	Contain Medicines Harmless Pharmaceutical Products Orofer S 100 5 ML Ferrous Ir…	$6.8K	1.4%
7	Contain Harmless Surgical Products- Details As Per the Attached Export Annexure…	$6.4K	1.3%
8	Contain Medicines Harmless Pharmaceutical Products - Cetuxa 100mg Injection (20…	$5.8K	1.2%
9	Contain Medicines Harmless Pharmaceutical Products - Details As Per Attached Ex…	$5.7K	1.2%
10	Micronized Purified Flavonoiod Fraction Brand Name Daflon 500mg Tablet	$5.6K	1.1%
11	Harmless Medicines for Human Consumption Termenghex-ex Syrup (120ml)	$4.9K	1.0%
12	Semaglutide Tablet 7mg - Rybelsus 7mg Tabletnos	$4.4K	0.9%
13	Harmless Medicines for Human Consumption Garcoxia-120 Tablets (3x10t)	$4.4K	0.9%
14	Product:cuerox 500; Content:cefuroxime a	$4.3K	0.9%
15	Xgeva 120mg Injection (1vial) Denosumab, Batchno: 1162595	$4.1K	0.9%

India exports 20+ pharmaceutical formulations to British Virgin Islands with a combined trade value of $485.3K. Key products include Tenofovir ($37K), Semaglutide ($4K), Cefuroxime ($4K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,180 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to British Virgin Islands Trade Routes

1Tenofovir$37K

2Semaglutide$4K

3Cefuroxime$4K

These are the top pharmaceutical products exported from India to British Virgin Islands, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, British Virgin Islands buyers, regulatory requirements, and logistics for that specific product corridor. Products include Tenofovir ($37K), Semaglutide ($4K), Cefuroxime ($4K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to British Virgin Islands

1Sara Trading Corporation

$205K

2Vea Impex (i) Private Limited

$68K

3Shree Ssd Pharma Private Limited

$45K

4Mylan Laboratories Limited

$37K

5Wellona Pharma

Port Analysis — India to British Virgin Islands Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)36.9%

SAHAR AIR32.0%

Bombay Air Cargo11.4%

MUNDRA SEA0.2%

JNPT/ NHAVA SHEVA SEA6.0%

British Virgin Islands Import Ports

TORTOLA61.7%

VIRGIN GORDA25.8%

BEEF ISLAND11.2%

Trade Statistics

Total Value$485K

Shipments1,180

Indian Exporters16

British Virgin Islands Buyers24

Avg Shipment$411

Products984

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

Supply Chain & Logistics — India to British Virgin Islands Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical shipments from India to the British Virgin Islands (BVI) primarily utilize sea and air transport. Sea routes involve transiting the Suez Canal, connecting the Indian Ocean to the Mediterranean Sea, followed by passage through the Atlantic Ocean to the Caribbean. Air routes typically involve flights from major Indian airports, such as Sahar Air Cargo (INBOM4) in Mumbai, to international hubs like London or New York, with subsequent connections to the BVI. The Suez Canal's strategic importance means that any disruptions, such as blockages, can significantly impact shipping schedules and transit times. For instance, the Ever Given incident in March 2021 caused a six-day blockage, leading to substantial delays in global shipping. While specific data on transit times from Indian ports to the BVI is limited, sea shipments generally take several weeks, whereas air shipments can range from a few days to a week, depending on layover durations and flight availability.

2Port Infrastructure

In India, Sahar Air Cargo (INBOM4) in Mumbai serves as a significant export hub for pharmaceutical shipments, handling 36.9% of the total exports in this corridor. Other notable export ports include Sahar Air (32.0%) and Bombay Air Cargo (11.4%). These facilities are equipped to handle temperature-sensitive goods, ensuring compliance with Good Distribution Practices (GDP). In the BVI, Tortola (61.7%), Virgin Gorda (25.8%), and Beef Island (11.2%) are the primary import ports for pharmaceutical products. These ports are equipped to handle pharmaceutical imports, including temperature-sensitive formulations, ensuring compliance with the National Drug Regulatory Authority's standards.

Market Opportunity Assessment — British Virgin Islands for Indian Pharma

Market size, healthcare system, growth outlook

1Market Size & Growth

The British Virgin Islands (BVI) operates a National Health Insurance (NHI) system, established on January 1, 2016, to provide comprehensive healthcare coverage to all residents. (bvi.gov.vg) While specific figures on the total pharmaceutical market size and growth rate are not publicly available, the NHI's extensive coverage—including pharmaceutical services—indicates a significant and growing demand for medical products. The BVI's reliance on imports for pharmaceutical needs suggests a substantial import dependency, with generic drugs likely comprising a significant portion of the market, given their cost-effectiveness.

2Healthcare System

The BVI's healthcare system is primarily managed by the BVI Health Services Authority (BVIHSA), a statutory body responsible for delivering public healthcare services across the territory. (gov.vg) The NHI scheme, administered by the Social Security Board, ensures that all residents have access to a wide range of healthcare services, including pharmaceuticals. (bvi.gov.vg) Additionally, private insurance providers, such as CG Insurance, offer individual and group health insurance plans, supplementing the NHI and providing additional coverage options for residents.

3Opportunity for Indian Exporters

The BVI's NHI system and reliance on imported pharmaceuticals present a promising opportunity for Indian pharmaceutical exporters. The market's import dependency and the cost-effectiveness of generic drugs align well with India's manufacturing capabilities. Given the NHI's comprehensive coverage, there is a consistent demand for a wide range of pharmaceutical products, including the top-selling items in the Indian export portfolio to the BVI, such as Tenofovir Disoproxil Fumarate, Daratumumab, and Enzalutamide. The growth outlook for Indian pharmaceutical exports to the BVI appears positive, driven by the expanding healthcare coverage and the ongoing need for imported medical products.

TransData Nexus Research · British Virgin Islands healthcare dataMar 2026

Competitive Landscape — India vs Other Pharmaceutical Suppliers to British Virgin Islands

Competing origins, India's edge, challenges and threats

1Competing Origins

The British Virgin Islands (BVI) sources pharmaceuticals from a diverse array of suppliers, including China, European Union (EU) manufacturers, domestic producers, and other emerging markets. While specific market share data is limited, available information indicates that India is a significant exporter to the region. For instance, in 2024, India exported pharmaceutical products worth approximately $485,000 to the BVI, comprising 1,180 shipments from 16 Indian exporters to 24 BVI buyers. This suggests a robust presence of Indian pharmaceutical products in the BVI market. However, the exact market shares of other suppliers, such as China, EU manufacturers, and domestic producers, are not readily available. The BVI's reliance on imports for pharmaceutical products underscores the importance of these international suppliers in meeting the territory's healthcare needs.

2India's Competitive Edge

India's pharmaceutical industry offers several competitive advantages that enhance its appeal to the BVI market. Notably, India is recognized for its cost competitiveness, providing high-quality medicines at affordable prices. This affordability is a significant factor in India's global pharmaceutical exports. Additionally, India's pharmaceutical sector boasts a broad portfolio, encompassing a wide range of generic medicines, vaccines, and specialized formulations. The country's adherence to Good Manufacturing Practices (GMP), including WHO-GMP standards, ensures regulatory compliance and product quality. Furthermore, India's large English-speaking workforce facilitates effective communication and collaboration with international partners. These factors collectively position India as a strong competitor in the BVI pharmaceutical market.

3Challenges & Threats

Despite its strengths, India's pharmaceutical exporters face several challenges in the BVI market. Regulatory tightening by the BVI's National Drug Regulatory Authority, which adheres to WHO-GMP standards, may impose stricter compliance requirements, potentially affecting market access. Competition from other suppliers, such as China and EU manufacturers, presents additional challenges, as these regions may offer competitive pricing and established trade relationships. Moreover, perceptions regarding the quality of Indian pharmaceuticals can vary, and addressing these perceptions is crucial for maintaining and expanding market share. Proactively engaging with regulatory bodies and emphasizing the quality and compliance of Indian products are essential strategies to mitigate these challenges.

TransData Nexus Research · Global trade databasesMar 2026

FAQ — India to British Virgin Islands Pharmaceutical Trade

What is the total value of India's pharmaceutical export to British Virgin Islands?

India exported pharmaceuticals worth $485.3K to British Virgin Islands across 1,180 verified shipments.

Who are the top Indian pharmaceutical exporters to British Virgin Islands?

1. SARA TRADING CORPORATION — $204.8K. 2. VEA IMPEX (I) PRIVATE LIMITED — $68.1K. 3. SHREE SSD PHARMA PRIVATE LIMITED — $45.3K. Total: 16 suppliers.

Which companies in British Virgin Islands import pharmaceuticals from India?

1. VANTERPOOL ENTERPRISES LTD — $165.2K. 2. TO THE ORDER OF INVOICE RAISED TO — $104.8K. 3. PROCUREMENT, — $36.9K. 24 buyers total.

What pharmaceutical products does India export most to British Virgin Islands?

1. Tenofovir Disoproxil Fumarate300 MG +efavirenz600mg+emtricitabine200mgtab30s (2… ($36.9K, 7.6%); 2. Contain Medicines Harmless Pharmaceutical Products- Darzalex 400mg Injection (2… ($16.3K, 3.4%); 3. Darzalex 400mg Injection (20 Ml) Daratumumab ($14.5K, 3.0%); 4. Contain Medicines Harmless Pharmaceutical Products - Darzalex 400mg Injection (… ($12.7K, 2.6%); 5. Enzalutamide 160mg Tablet -brand Name-glenza 160mg Tablet ($7.5K, 1.5%)

Which ports handle pharmaceutical shipments from India to British Virgin Islands?

Export: SAHAR AIR CARGO ACC (INBOM4), SAHAR AIR, Bombay Air Cargo, MUNDRA SEA, JNPT/ NHAVA SHEVA SEA. Import: TORTOLA, VIRGIN GORDA, BEEF ISLAND.

Why does British Virgin Islands import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $485.3K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply British Virgin Islands?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to British Virgin Islands pharmaceutical trade?

$411 per consignment across 1,180 shipments.

How many Indian pharmaceutical companies export to British Virgin Islands?

16 Indian companies. Largest: SARA TRADING CORPORATION with $204.8K.

How can I find verified Indian pharmaceutical suppliers for British Virgin Islands?

TransData Nexus covers 16 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to British Virgin Islands identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,180 verified shipments from 16 Indian exporters to 24 British Virgin Islands buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

16 Exporters

24 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to British Virgin Islands Pharmaceutical Export